One patient with schizophrenia showed reduced drug-induced extrapyramidal symptoms as a result of an alternative regimen of treatment with paliperidone 3 and 6 mg every other day

• Published in: SAGE open medical case reports Vol. 5; p. 2050313X17742836
• Main Authors: Suzuki, Hidenobu, Hibino, Hiroyuki, Inoue, Yuichi, Matsumoto, Hideo, Mikami, Katsunaka
• Format: Journal Article
• Language: English
• Published: London, England SAGE Publications 01.01.2017; Sage Publications Ltd; SAGE Publishing
• Subjects: Antipsychotics; Case Report; Case reports; Schizophrenia; schizophrenia; Paliperidone; extrapyramidal symptoms; tapering dose; maintenance phase
• ISSN: 2050-313X; 2050-313X
• DOI: 10.1177/2050313X17742836

Background: Schizophrenia is a chronic disease that requires long-term management with antipsychotics. Antipsychotic drugs are given by tapering their dose, extending the dosing interval, and so on, as part of a treatment strategy to minimize the adverse effects while at the same time maintaining efficacy. Methods: We report the case of one patient with schizophrenia in whom the clinical symptoms were alleviated after treatment with 6 mg paliperidone. However, the patient developed extrapyramidal syndrome, for which 3 and 6 mg paliperidone were administered alternately every other day. Extrapyramidal syndrome was assessed using the Drug-Induced Extrapyramidal Symptoms Scale, Abnormal Involuntary Movement Scale, or Barnes Akathisia Scale. Results: There was improvement in Drug-Induced Extrapyramidal Symptoms Scale score and Abnormal Involuntary Movement Scale score. However, there was almost no change in the Positive and Negative Syndrome Scale total score, positive score, negative score, or general score. Conclusion: The results indicate the possibility of lessened adverse effects as a result of an alternative regimen of treatment with paliperidone 3 and 6 mg every other day in the maintenance phase.